UPDATE: Agilent to Offer Senior Notes; Fitch Rates Offering BBB+ | GenomeWeb

The story has been updated with information about the pricing of the notes released by Agilent after the close of the market.

NEW YORK (GenomeWeb News) – Agilent Technologies today announced it is offering a series of senior notes, partly to fund its restructuring initiative and expand its share buyback program.

Separately, Fitch Ratings assigned a BBB+ rating to the offering.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.

In Science this week: global genetic diversity map, and more.